ID   STK39_HUMAN             Reviewed;         545 AA.
AC   Q9UEW8; O14774; Q53S90; Q53SL7; Q53SS1; Q9UER4; X5D9C8;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2011, sequence version 3.
DT   10-MAY-2017, entry version 167.
DE   RecName: Full=STE20/SPS1-related proline-alanine-rich protein kinase;
DE            Short=Ste-20-related kinase;
DE            EC=2.7.11.1;
DE   AltName: Full=DCHT;
DE   AltName: Full=Serine/threonine-protein kinase 39;
GN   Name=STK39; Synonyms=SPAK;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=10980603; DOI=10.1038/sj.onc.1203784;
RA   Johnston A.M., Naselli G., Gonez L.J., Martin R.M., Harrison L.C.,
RA   de Aizpurua H.J.;
RT   "SPAK, a STE20/SPS1-related kinase that activates the p38 pathway.";
RL   Oncogene 19:4290-4297(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=24722188; DOI=10.1038/ncomms4650;
RA   Corominas R., Yang X., Lin G.N., Kang S., Shen Y., Ghamsari L.,
RA   Broly M., Rodriguez M., Tam S., Wanamaker S.A., Fan C., Yi S.,
RA   Tasan M., Lemmens I., Kuang X., Zhao N., Malhotra D., Michaelson J.J.,
RA   Vacic V., Calderwood M.A., Roth F.P., Tavernier J., Horvath S.,
RA   Salehi-Ashtiani K., Korkin D., Sebat J., Hill D.E., Hao T., Vidal M.,
RA   Iakoucheva L.M.;
RT   "Protein interaction network of alternatively spliced isoforms from
RT   brain links genetic risk factors for autism.";
RL   Nat. Commun. 5:3650-3650(2014).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Melnick M.B., Petitt M., Perrimon N., Comb M.J.;
RT   "New human member of the Ste20 family.";
RL   Submitted (OCT-1997) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 279-545 (ISOFORM 1).
RC   TISSUE=Testis;
RA   Baytel D., Don J.;
RL   Submitted (AUG-1997) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   PHOSPHORYLATION AT SER-309.
RX   PubMed=14988727; DOI=10.1038/sj.emboj.7600125;
RA   Li Y., Hu J., Vita R., Sun B., Tabata H., Altman A.;
RT   "SPAK kinase is a substrate and target of PKCtheta in T-cell receptor-
RT   induced AP-1 activation pathway.";
RL   EMBO J. 23:1112-1122(2004).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-385, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Prostate cancer;
RX   PubMed=17487921; DOI=10.1002/elps.200600782;
RA   Giorgianni F., Zhao Y., Desiderio D.M., Beranova-Giorgianni S.;
RT   "Toward a global characterization of the phosphoproteome in prostate
RT   cancer cells: identification of phosphoproteins in the LNCaP cell
RT   line.";
RL   Electrophoresis 28:2027-2034(2007).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-370; SER-371 AND
RP   SER-385, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-385, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-349, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-385, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-385, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-354 AND SER-385, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: May act as a mediator of stress-activated signals.
CC       Mediates the inhibiton of SLC4A4, SLC26A6 as well as CFTR
CC       activities by the WNK scaffolds, probably through phosphorylation.
CC       {ECO:0000250|UniProtKB:Q9Z1W9}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- SUBUNIT: The phosphorylated form forms a complex with WNK2.
CC       {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q9Y376:CAB39; NbExp=4; IntAct=EBI-2680974, EBI-306905;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}. Nucleus
CC       {ECO:0000305}. Note=Nucleus when caspase-cleaved. {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9UEW8-1; Sequence=Displayed;
CC       Name=2; Synonyms=A;
CC         IsoId=Q9UEW8-2; Sequence=VSP_055889;
CC   -!- TISSUE SPECIFICITY: Predominantly expressed in brain and pancreas
CC       followed by heart, lung, kidney, skeletal muscle, liver, placenta
CC       and testis.
CC   -!- DOMAIN: PAPA box (proline-alanine repeats) may target the kinase
CC       to a specific subcellular location by facilitating interaction
CC       with intracellular proteins such as actin or actin-like proteins.
CC   -!- PTM: Phosphorylated at Ser-309 by PRKCQ.
CC       {ECO:0000269|PubMed:14988727}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. STE Ser/Thr
CC       protein kinase family. STE20 subfamily. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF099989; AAC72238.1; -; mRNA.
DR   EMBL; KJ534948; AHW56588.1; -; mRNA.
DR   EMBL; AF030403; AAD01901.1; -; mRNA.
DR   EMBL; AC016723; AAY15003.1; -; Genomic_DNA.
DR   EMBL; AC017069; AAY14897.1; -; Genomic_DNA.
DR   EMBL; AC067940; AAY24032.1; -; Genomic_DNA.
DR   EMBL; AF017635; AAB70552.1; -; mRNA.
DR   CCDS; CCDS42770.1; -. [Q9UEW8-1]
DR   RefSeq; NP_037365.2; NM_013233.2. [Q9UEW8-1]
DR   UniGene; Hs.276271; -.
DR   ProteinModelPortal; Q9UEW8; -.
DR   SMR; Q9UEW8; -.
DR   BioGrid; 118159; 31.
DR   IntAct; Q9UEW8; 7.
DR   MINT; MINT-6783158; -.
DR   STRING; 9606.ENSP00000348278; -.
DR   BindingDB; Q9UEW8; -.
DR   ChEMBL; CHEMBL1163108; -.
DR   GuidetoPHARMACOLOGY; 2224; -.
DR   iPTMnet; Q9UEW8; -.
DR   PhosphoSitePlus; Q9UEW8; -.
DR   BioMuta; STK39; -.
DR   DMDM; 317373508; -.
DR   EPD; Q9UEW8; -.
DR   PaxDb; Q9UEW8; -.
DR   PeptideAtlas; Q9UEW8; -.
DR   PRIDE; Q9UEW8; -.
DR   DNASU; 27347; -.
DR   Ensembl; ENST00000355999; ENSP00000348278; ENSG00000198648. [Q9UEW8-1]
DR   GeneID; 27347; -.
DR   KEGG; hsa:27347; -.
DR   UCSC; uc002uea.4; human. [Q9UEW8-1]
DR   CTD; 27347; -.
DR   DisGeNET; 27347; -.
DR   GeneCards; STK39; -.
DR   H-InvDB; HIX0023910; -.
DR   HGNC; HGNC:17717; STK39.
DR   HPA; CAB046022; -.
DR   HPA; HPA061803; -.
DR   HPA; HPA062802; -.
DR   MIM; 607648; gene.
DR   neXtProt; NX_Q9UEW8; -.
DR   OpenTargets; ENSG00000198648; -.
DR   PharmGKB; PA38243; -.
DR   eggNOG; KOG0582; Eukaryota.
DR   eggNOG; ENOG410XSWS; LUCA.
DR   GeneTree; ENSGT00860000133680; -.
DR   HOGENOM; HOG000234204; -.
DR   HOVERGEN; HBG108518; -.
DR   InParanoid; Q9UEW8; -.
DR   KO; K08835; -.
DR   OMA; REASSCA; -.
DR   OrthoDB; EOG091G0AKO; -.
DR   PhylomeDB; Q9UEW8; -.
DR   TreeFam; TF105339; -.
DR   BRENDA; 2.7.11.1; 2681.
DR   SignaLink; Q9UEW8; -.
DR   SIGNOR; Q9UEW8; -.
DR   ChiTaRS; STK39; human.
DR   GeneWiki; STK39; -.
DR   GenomeRNAi; 27347; -.
DR   PRO; PR:Q9UEW8; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   Bgee; ENSG00000198648; -.
DR   CleanEx; HS_STK39; -.
DR   Genevisible; Q9UEW8; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IEA:Ensembl.
DR   GO; GO:0016323; C:basolateral plasma membrane; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005856; C:cytoskeleton; IEA:Ensembl.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0019898; C:extrinsic component of membrane; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; NAS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016301; F:kinase activity; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0019901; F:protein kinase binding; IEA:Ensembl.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0004702; F:signal transducer, downstream of receptor, with serine/threonine kinase activity; IBA:GO_Central.
DR   GO; GO:0071476; P:cellular hypotonic response; IC:ParkinsonsUK-UCL.
DR   GO; GO:0035556; P:intracellular signal transduction; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0036438; P:maintenance of lens transparency; ISS:ParkinsonsUK-UCL.
DR   GO; GO:1905408; P:negative regulation of creatine transmembrane transporter activity; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0090188; P:negative regulation of pancreatic juice secretion; IEA:Ensembl.
DR   GO; GO:1901380; P:negative regulation of potassium ion transmembrane transport; IDA:ParkinsonsUK-UCL.
DR   GO; GO:1901017; P:negative regulation of potassium ion transmembrane transporter activity; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0001933; P:negative regulation of protein phosphorylation; IEA:Ensembl.
DR   GO; GO:2000687; P:negative regulation of rubidium ion transmembrane transporter activity; IDA:ParkinsonsUK-UCL.
DR   GO; GO:2000681; P:negative regulation of rubidium ion transport; IDA:ParkinsonsUK-UCL.
DR   GO; GO:2000650; P:negative regulation of sodium ion transmembrane transporter activity; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0018105; P:peptidyl-serine phosphorylation; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0018107; P:peptidyl-threonine phosphorylation; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0032414; P:positive regulation of ion transmembrane transporter activity; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0043268; P:positive regulation of potassium ion transport; IEA:Ensembl.
DR   GO; GO:0046777; P:protein autophosphorylation; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0006468; P:protein phosphorylation; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0008217; P:regulation of blood pressure; IEA:Ensembl.
DR   GO; GO:0050727; P:regulation of inflammatory response; IEA:Ensembl.
DR   GO; GO:2000021; P:regulation of ion homeostasis; IEA:Ensembl.
DR   GO; GO:0006950; P:response to stress; NAS:UniProtKB.
DR   GO; GO:0023014; P:signal transduction by protein phosphorylation; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0023016; P:signal transduction by trans-phosphorylation; IMP:ParkinsonsUK-UCL.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR024678; Kinase_OSR1/WNK_CCT.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   Pfam; PF12202; OSR1_C; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; ATP-binding; Complete proteome;
KW   Cytoplasm; Kinase; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Serine/threonine-protein kinase; Transferase.
FT   CHAIN         1    545       STE20/SPS1-related proline-alanine-rich
FT                                protein kinase.
FT                                /FTId=PRO_0000086722.
FT   DOMAIN       63    337       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND      69     77       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOTIF       360    366       Nuclear localization signal.
FT                                {ECO:0000255}.
FT   MOTIF       387    391       Caspase cleavage related site.
FT   COMPBIAS     12     53       Ala/Pro-rich.
FT   ACT_SITE    192    192       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   BINDING      92     92       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES     309    309       Phosphoserine; by PKC/PRKCQ.
FT                                {ECO:0000269|PubMed:14988727}.
FT   MOD_RES     349    349       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     354    354       Phosphothreonine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     370    370       Phosphoserine.
FT                                {ECO:0000244|PubMed:18088087}.
FT   MOD_RES     371    371       Phosphoserine.
FT                                {ECO:0000244|PubMed:18088087}.
FT   MOD_RES     385    385       Phosphoserine.
FT                                {ECO:0000244|PubMed:17487921,
FT                                ECO:0000244|PubMed:18088087,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:20068231,
FT                                ECO:0000244|PubMed:21406692,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     393    393       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q9Z1W9}.
FT   VAR_SEQ      28     46       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:24722188}.
FT                                /FTId=VSP_055889.
FT   CONFLICT     41     41       A -> AAP (in Ref. 1; AAC72238 and 3;
FT                                AAD01901). {ECO:0000305}.
FT   CONFLICT    173    173       L -> F (in Ref. 3; AAD01901).
FT                                {ECO:0000305}.
FT   CONFLICT    416    416       A -> V (in Ref. 2; AHW56588).
FT                                {ECO:0000305}.
SQ   SEQUENCE   545 AA;  59474 MW;  35E68F400A38A861 CRC64;
     MAEPSGSPVH VQLPQQAAPV TAAAAAAPAA ATAAPAPAAP AAPAPAPAPA AQAVGWPICR
     DAYELQEVIG SGATAVVQAA LCKPRQERVA IKRINLEKCQ TSMDELLKEI QAMSQCSHPN
     VVTYYTSFVV KDELWLVMKL LSGGSMLDII KYIVNRGEHK NGVLEEAIIA TILKEVLEGL
     DYLHRNGQIH RDLKAGNILL GEDGSVQIAD FGVSAFLATG GDVTRNKVRK TFVGTPCWMA
     PEVMEQVRGY DFKADMWSFG ITAIELATGA APYHKYPPMK VLMLTLQNDP PTLETGVEDK
     EMMKKYGKSF RKLLSLCLQK DPSKRPTAAE LLKCKFFQKA KNREYLIEKL LTRTPDIAQR
     AKKVRRVPGS SGHLHKTEDG DWEWSDDEMD EKSEEGKAAF SQEKSRRVKE ENPEIAVSAS
     TIPEQIQSLS VHDSQGPPNA NEDYREASSC AVNLVLRLRN SRKELNDIRF EFTPGRDTAD
     GVSQELFSAG LVDGHDVVIV AANLQKIVDD PKALKTLTFK LASGCDGSEI PDEVKLIGFA
     QLSVS
//
